Risk factors for progressive multifocal leukoencephalopathy identified in natalizumab-treated patients

被引：0
|
作者：
机构：
来源：
Nature Reviews Neurology | 2012年 / 8卷 / 7期
关键词：
D O I：
10.1038/nrneurol.2012.122
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：358 / 358
相关论文
共 50 条
  • [1] Updated analysis of progressive multifocal leukoencephalopathy risk factors in natalizumab-treated multiple sclerosis patients
    Bloomgren, G.
    Richman, S.
    Arnold, R.
    Subramanyam, M.
    Natarajan, A.
    Lee, S.
    Plavina, T.
    Scanlon, J.
    Sandrock, A.
    Bozic, C.
    JOURNAL OF NEUROLOGY, 2012, 259 : S37 - S37
  • [2] Risk perception about progressive multifocal leukoencephalopathy in natalizumab-treated patients and their neurologists
    Koepke, Sascha
    Kleiter, Ingo
    Gaissmaier, Wolfgang
    Heesen, Christoph
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (08) : 999 - 999
  • [3] Updated Incidence of Progressive Multifocal Leukoencephalopathy in Natalizumab-Treated Multiple Sclerosis Patients Stratified by Established Risk Factors
    Bloomgren, Gary
    Richman, Sandra
    Hotermans, Christophe
    Subramanyam, Meena
    Natarajan, Amy
    Lee, Sophia
    Plavina, Tatiana
    Scanlon, James
    Sandrock, Alfred
    Bozic, Carmen
    NEUROLOGY, 2012, 78
  • [4] Efficacy and safety of switching to Ocrelizumab in Natalizumab-treated patients at high risk of progressive multifocal leukoencephalopathy
    Valero Lopez, Gabriel
    Millan Pascual, Jorge
    Moreno Arjona, Maria de la Paz
    Arnaldos Illan, Pedro Lucas
    Ibanez Gabarron, Luis
    Valero Lopez, Angel
    Sanchez Garcia, Carmen Maria
    Hernandez Leon, Adelaida
    Dos Santos Espana, Camila
    Gomollon Martos, Penelope
    Iniesta Martinez, Francisca
    Meca Lallana, Jose E.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1037 - 1038
  • [5] Immunological biomarkers identifying natalizumab-treated multiple sclerosis patients at risk of progressive multifocal leukoencephalopathy
    Serana, Federico
    Chiarini, Marco
    Sottini, Alessandra
    Bertoli, Diego
    Giustini, Viviana
    Tessitore, Marion Vaglio
    Caimi, Luigi
    Capra, Ruggero
    Imberti, Luisa
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 277 (1-2) : 6 - 12
  • [6] Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence
    Bacchetta, Frederic
    Mathias, Amandine
    Schluep, Myriam
    Du Pasquier, Renaud
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 300 - 303
  • [7] Matrix Metalloproteinase 9 Is Decreased in Natalizumab-Treated Multiple Sclerosis Patients at Risk for Progressive Multifocal Leukoencephalopathy
    Fissolo, Nicolas
    Pignolet, Beatrice
    Matute-Blanch, Clara
    Trivino, Juan Carlos
    Miro, Berta
    Mota, Miriam
    Perez-Hoyos, Santiago
    Sanchez, Alex
    Vermersch, Patrick
    Ruet, Aurelie
    Vermersch, Patrick
    Ruet, Aurelie
    de Seze, Jerome
    Labauge, Pierre
    Vukusic, Sandra
    Papeix, Caroline
    Almoyna, Laurent
    Tourbah, Ayman
    Clavelou, Pierre
    Moreau, Thibault
    Pelletier, Jean
    Lebrun-Frenay, Christine
    Montalban, Xavier
    Brassat, David
    Comabella, Manuel
    ANNALS OF NEUROLOGY, 2017, 82 (02) : 186 - 195
  • [8] Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
    Sorensen, Per Soelberg
    Bertolotto, Antonio
    Edan, Gilles
    Giovannoni, Gavin
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Kieseier, Bernd C.
    Montalban, Xavier
    Olsson, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (02) : 143 - 152
  • [9] Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients
    Rossi, Francesca
    Newsome, Scott D.
    Viscidi, Raphael
    MOLECULAR AND CELLULAR PROBES, 2015, 29 (01) : 54 - 62
  • [10] Progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients in Spain: more than expected?
    Castillo-Trivino, T.
    Arroyo, R.
    De Andres, C.
    Fernandez-Bolanos, R.
    Garcia-Merino, A.
    Landete, L.
    Menendez, M.
    Oliva, P.
    Oterino, A.
    Paramo, M. D.
    Saiz, A.
    Olascoaga, J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 370 - 370
12345